nbcmiami.com
3 young people advocate for cure to Crohn's ahead of South Florida weekend walk
Personal stories show how IBD affects daily life and mental health and point to local fundraising and community support opportunities. The article names a commonly used biologic (Remicade/infliximab) and describes symptom burden and diagnostic testing relevant to people with IBD.
People with Crohn’s disease or ulcerative colitis, parents and caregivers of children with IBD, local community members interested in advocacy or fundraising, and clinicians who support pediatric/adolescent patients.
What To Know
Three young people in South Florida are highlighted ahead of a Crohn’s & Colitis Foundation Take Steps charity walk that aims to raise money and awareness.
The story profiles a 21‑year‑old who transitioned from an initial ulcerative colitis diagnosis to Crohn’s disease, a 17‑year‑old who receives IV Remicade infusions about every six to seven weeks, and a 12‑year‑old participant whose team is fundraising.
The piece focuses on personal experiences, advocacy, and community support rather than clinical study results or new treatments. The article notes symptoms (weight loss, stomach pain, frequent bathroom use) and that a colonoscopy changed one person’s diagnosis. It names Remicade (infliximab) as the infusion therapy one teen receives.
The event (Take Steps walk) and teams raising funds are central to the report. This is a human-interest/community-awareness article — it’s useful for people looking for local support, peer stories, and fundraising involvement, but it does not provide clinical guidance or new medical evidence.
This is a local news human-interest piece focused on advocacy and fundraising. It does not report new clinical research, treatment comparisons, or practice-changing findings. Individual treatment details (like infusion timing) are personal reports and may vary for others.
